Ross Portaro
Vertrieb & Marketing bei VENUS CONCEPT INC.
Vermögen: 6 868 $ am 30.04.2024
Aktive Positionen von Ross Portaro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VENUS CONCEPT INC. | Vertrieb & Marketing | 15.10.2021 | - |
Corporate Officer/Principal | 01.05.2021 | 15.10.2021 |
Karriereverlauf von Ross Portaro
Ehemalige bekannte Positionen von Ross Portaro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TREX WIND-DOWN, INC. | Vertrieb & Marketing | 01.01.2014 | 01.01.2016 |
Coherent Medical Group
Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a private company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Corporate Officer/Principal | - | - |
CUTERA, INC. | Vertrieb & Marketing | - | - |
Ausbildung von Ross Portaro
McIntire School of Commerce | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Kanada | 2 |
Operativ
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CUTERA, INC. | Health Technology |
VENUS CONCEPT INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Coherent Medical Group
Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a private company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Health Technology |
BioPharmX Corp.
BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
- Börse
- Insiders
- Ross Portaro
- Erfahrung